KoBioLabs, Inc (KOSDAQ:348150)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,240.00
+180.00 (3.56%)
At close: Jul 11, 2025, 3:30 PM KST

KoBioLabs Revenue

KoBioLabs had revenue of 17.30B KRW in the quarter ending March 31, 2025, with 16.02% growth. This brings the company's revenue in the last twelve months to 70.75B, up 75.33% year-over-year. In the year 2024, KoBioLabs had annual revenue of 68.36B with 106.28% growth.

Revenue (ttm)
70.75B
Revenue Growth
+75.33%
P/S Ratio
1.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
101.75B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 68.36B 35.22B 106.28%
Dec 31, 2023 33.14B 21.53B 185.54%
Dec 31, 2022 11.61B 8.71B 301.12%
Dec 31, 2021 2.89B -1.70B -36.98%
Dec 31, 2020 4.59B 4.01B 696.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
Samsung Biologics 4,898.69B
LG Energy Solution 25.76T
Hyundai Motor Company 178.98T
KB Financial Group 14.93T
Doosan Enerbility 15.88T
Celltrion 3,662.23B
Revenue Rankings